Industry News
DNA Computation Performed In Living Cells
Jul 15, 2013
Chemists from North Carolina State University have performed a DNA-based logic-gate operation within a human cell. The research may pave the way to more complicated computations in live cells, as well as new methods of disease detection and treatment... Read More
Molecular Discovery Puts Cancer Treatment In A New Perspective
Jul 15, 2013
Researchers from the University of Copenhagen and the National Institutes of Health have obtained ground-breaking new knowledge about proteases - important enzymes which, among other things, play a role in the development of cancer cells. The findings may be significant for the development of cancer drugs, and have just been published in Journal of Biological Chemistry... Read More
Study: Women Who Survived Childhood Cancer Still Have Good Chance Of Conceiving
Jul 14, 2013
Researchers have found that although females who survived cancer in their childhood have an increased risk of infertility, they still have a good chance of conceiving. The study, published in The Lancet Oncology, revealed that around two-thirds of women who suffered from childhood cancer become pregnant... Read More
Researchers Discover A Role For A Protein That Has Implications For Treatment Of Cancer And Heart Disease
Jul 14, 2013
St. Jude Children's Research Hospital scientists have discovered that a protein used by cancer cells to evade death also plays a vital role in heart health. This dual role complicates efforts to develop cancer drugs that target the protein, but may lead to new therapies for heart muscle damage. The research appeared in a recent edition of the scientific journal Genes & Development... Read More
Researchers Develop New Method For Tracking Cell Signaling
Jul 14, 2013
Researchers at Memorial Sloan-Kettering Cancer Center, together with collaborators in Germany, have developed a new method for identifying the cell of origin of intracellular and secreted proteins within multicellular environments... Read More
Late Stage Lung Cancer Drug Gilotrif (Afatinib) Approved By FDA
Jul 13, 2013
The FDA has approved the use of Gilotrif (afatinib) to treat patients with non-small cell lung cancer (NSCLC) who have certain epidermal growth factor receptor (EGFR) gene mutations in their tumors. Lung cancer is one of the leading cancer-killers, with an estimated 159,480 people dying from the disease this year in the U.S. alone... Read More
FDA Approves New Drug "Gilotrif" For Patients With Non-Small Cell Lung Cancer
Jul 13, 2013
The FDA has just approved the use of Gilotrif (afatinib) to treat patients with non-small cell lung cancer (NSCLC) who have certain epidermal growth factor receptor (EGFR) gene mutations in their tumors. Lung cancer is one of the leading cancer-killers, with an estimated 159,480 people dying from the disease this year in the U.S. alone... Read More
New Approach Could Enhance Cancer Drug Delivery
Jul 13, 2013
Researchers have developed a concept to potentially improve delivery of drugs for cancer treatment using nanoparticles that concentrate and expand in the presence of higher acidity found in tumor cells... Read More
Belly Fat Tied to Raised Heart and Cancer Risks
Jul 12, 2013
Carrying too much fat around the abdomen puts people at greater risk for heart disease and cancer compared with people who have a similar body mass index (BMI) but who carry their fat in other parts of the body. So says a US study published online in the July issue of the Journal of the American College of Cardiology... Read More
New Treatment For Management Of Advanced Prostate Cancer After First-Line Hormonal Treatments And Docetaxel Chemotherapy Failure, Available In UK
Jul 12, 2013
Available now, XTANDI TM (enzalutamide) has been licensed for the treatment of men with advanced prostate cancer whose disease has become resistant to first-line hormonal treatments and has progressed following docetaxel chemotherapy[i], marking an important step in managing prostate cancer, which is the most common cancer among males in the UK... Read More
Previous Page Next Page
